Whole Exome Sequencing Market Emerging Opportunities, Comprehensive Research Study, Future Trends and Forecasts 2028
Emergen Research Logo
Whole exome sequencing is a widely used and important next-generation sequencing technique that efficiently sequences all protein-coding regions in a genome.
VANCOUER, BC, CANADA, June 1, 2022 /EINPresswire.com/ -- The global whole exome sequencing market size is expected to be significantly robust in 2028 and register a steady revenue CAGR during the forecast period, according to the latest report by Emergen Research. Increasing incidence of genetic disorders, rising awareness regarding whole exome sequencing, and rapid development of advanced diagnostic methods for treatment of genetic disorders are key factors expected to drive market revenue growth. In addition, whole exome sequencing is cost-effective as compared to whole genome sequencing methods and has a higher efficiency of detecting genetic variations or mutations that alter protein sequences and this has boosted its adoption in academic and scientific research
Get FREE Whole Exome Sequencing Market Report sample copy @ https://www.emergenresearch.com/request-sample/790
Market Dynamics:
Whole exome sequencing is a widely used and important next-generation sequencing technique that efficiently sequences all protein-coding regions in a genome. Whole exome sequencing is primarily used to screen and identify variations and mutations in the protein-coding regions. Whole exome sequencing can accurately detect genetic mutations that are related to birth defects and development delays. Increasing awareness regarding benefits of whole exome sequencing in detecting genetic disorders, rising investment to accelerate genomics and proteomics research, and adoption of cutting-edge technologies are key factors expected to drive market revenue growth over the forecast period.
๐๐ก๐จ๐ฅ๐ ๐๐ฑ๐จ๐ฆ๐ ๐๐๐ช๐ฎ๐๐ง๐๐ข๐ง๐ ๐๐๐ซ๐ค๐๐ญ : ๐๐จ๐ฆ๐ฉ๐๐ญ๐ข๐ญ๐ข๐ฏ๐ ๐๐๐ง๐๐ฌ๐๐๐ฉ๐
The prominent players operating in the Whole Exome Sequencing Market are profiled in-depth in the report and their strategies, collaborations, and product innovations. The analysis of the key players and their strategies to fortify their presence in the market impart a better understanding of the competitive landscape of the Electronic Health Records Market.
๐๐๐ฃ๐จ๐ซ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ ๐ข๐ง ๐ญ๐ก๐ ๐๐ฅ๐จ๐๐๐ฅ ๐๐ก๐จ๐ฅ๐ ๐๐ฑ๐จ๐ฆ๐ ๐๐๐ช๐ฎ๐๐ง๐๐ข๐ง๐ ๐๐๐ซ๐ค๐๐ญ ๐๐ง๐๐ฅ๐ฎ๐๐:
Illumina, Inc.
Life Technologies
Roche NimbleGen, Inc.
Agilent Technologies
BGI (Beijing Genomics Institute)
Eurofins Genomics, Inc.
Sengenics
GENEWIZ, Inc.
Knome, Inc.
Macrogen, Inc.
Ambry Genetics
๐๐๐ซ๐ฏ๐ข๐๐๐ฌ ๐๐๐ ๐ฆ๐๐ง๐ญ ๐๐๐๐จ๐ฎ๐ง๐ญ๐๐ ๐๐จ๐ซ ๐๐๐ซ๐ ๐๐ฌ๐ญ ๐๐๐ฏ๐๐ง๐ฎ๐ ๐๐ก๐๐ซ๐ ๐ข๐ง ๐๐๐๐:
The services segment accounted for the largest revenue share in the global market in 2020. Services is further segmented into sequencing and data analysis services. Increase in demand for high-throughput sequencing and data analysis services due to their advantages such as advanced bioinformatics visualization and low-cost sequencing and data management is a key factor driving this segmentโs growth. Sequence analysis services usually include experimental design, library generation from samples, and downstream analysis of DNA sequences.
๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐๐ง๐ญ๐๐ซ๐ฌ & ๐๐๐๐๐๐ฆ๐ข๐ ๐๐ง๐ฌ๐ญ๐ข๐ญ๐ฎ๐ญ๐ข๐จ๐ง๐ฌ ๐๐๐ ๐ฆ๐๐ง๐ญ ๐ญ๐จ ๐๐๐๐จ๐ฎ๐ง๐ญ ๐๐จ๐ซ ๐ ๐๐ฌ๐ญ๐๐ฌ๐ญ ๐๐๐ฏ๐๐ง๐ฎ๐ ๐๐๐๐:
Based on end-use, the global whole exome sequencing market is segmented into hospitals & clinics, pharmaceutical & biotechnology companies, research centers & academic institutions, and others. The research centers & academic institutions segment is projected to register the fastest revenue growth rate over the forecast period. Factors contributing to this segmentโs growth are growing demand for advanced therapeutics and personalized medicine, increasing investments by government bodies in genomic research programs, growing use of whole exome sequencing in clinical genetic laboratories, and increasing use of the technology in diagnosis and treatment of cancer and other chronic illnesses.
๐๐จ๐ซ๐ญ๐ก ๐๐ฆ๐๐ซ๐ข๐๐ ๐๐๐๐จ๐ฎ๐ง๐ญ๐๐ ๐๐จ๐ซ ๐๐๐ซ๐ ๐๐ฌ๐ญ ๐๐๐ฏ๐๐ง๐ฎ๐ ๐๐ก๐๐ซ๐ ๐ข๐ง ๐๐๐๐:
Among regional markets, the North America whole exome sequencing market accounted for the largest revenue share in the global market in 2020. Growing prevalence of chronic and genetic disorders, rising demand for personalized medicine, increasing adoption of whole exome sequencing technology for development of develop advanced diagnostics, and increasing genomic R&D activities are major factors bolstering the North America market revenue growth. Revenue growth is further driven by factors such as increased government funding for cancer research and presence of leading market players in the region, including Illumina, Inc., Agilent Technologies, and Life Technologies.
๐๐๐๐๐ฌ๐ฌ ๐ญ๐ก๐ ๐๐ง๐ญ๐ข๐ซ๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐ฉ๐๐๐ค๐๐ ๐ฐ๐ข๐ญ๐ก ๐๐๐, ๐๐๐๐ฅ๐๐ฌ ๐๐ง๐ ๐ ๐ข๐ ๐ฎ๐ซ๐๐ฌ ๐๐ง๐ ๐๐ฎ๐ญ๐ฅ๐ข๐ง๐ ๐จ๐ ๐๐ซ๐จ๐ฆ๐ข๐ง๐๐ง๐ญ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ @ https://www.emergenresearch.com/industry-report/whole-exome-sequencing-market
๐๐ฅ๐จ๐๐๐ฅ ๐๐ก๐จ๐ฅ๐ ๐๐ฑ๐จ๐ฆ๐ ๐๐๐ช๐ฎ๐๐ง๐๐ข๐ง๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง :
Emergen Research has segmented the global Blockchain in Genomics Market on the basis of service, business model, application, end-use, and region:
Service Outlook (Revenue, USD Million; 2017-2027)
Utility
Platforms
Business Model Outlook (Revenue, USD Million; 2017-2027)
Business to Customer (B2C)
Business to Business (B2B)
Customer to Business (C2B)
Application Outlook (Revenue, USD Million; 2017-2027)
Data Storage & Security
Data Sharing and Monetization
Automated Health Insurance
End-Use Outlook (Revenue, USD Million; 2017-2027)
Hospitals
Pharmaceutical and Biotechnology
Research Institutes
๐๐ก๐จ๐ฅ๐ ๐๐ฑ๐จ๐ฆ๐ ๐๐๐ช๐ฎ๐๐ง๐๐ข๐ง๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ ๐ข๐ง๐ช๐ฎ๐ข๐ซ๐ฒ ๐๐ง๐ ๐ซ๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐จ๐ซ ๐๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐๐ญ๐ข๐จ๐ง @ https://www.emergenresearch.com/request-for-customization/790
Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering:
United States
Europe
China
Japan
Southeast Asia
India
We can also provide the customized separate regional or country-level reports, for the following regions:
North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & Africa
๐๐ก๐ฒ ๐ฌ๐ก๐จ๐ฎ๐ฅ๐ ๐ฒ๐จ๐ฎ ๐๐ฎ๐ฒ ๐ญ๐ก๐ข๐ฌ ๐๐ก๐จ๐ฅ๐ ๐๐ฑ๐จ๐ฆ๐ ๐๐๐ช๐ฎ๐๐ง๐๐ข๐ง๐ ๐๐๐ซ๐ค๐๐ญ ๐ซ๐๐ฉ๐จ๐ซ๐ญ?
The study paper dissects the total market potential of major regions with strengths, opportunity and challenge, constraints, and dangers.
By identifying the high-improvement locations, the study inspects the open entryways, keeping an eye out for accomplices.
It examines each submarket in terms of a single improvement design and its contribution to the market.
It examines the recent developments, such as advancements, business strategies, new product releases, and acquisitions.
It purposefully profiles the major market players and thoroughly investigates their advancement strategies.
๐๐๐ค๐ ๐ ๐๐จ๐จ๐ค ๐๐ญ ๐จ๐ฎ๐ซ ๐จ๐ญ๐ก๐๐ซ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ:
single cell sequencing market
synthetic blood substitutes market
rehabilitation robotics market
alopecia market
https://www.google.com.ar/url?q=https://www.emergenresearch.com/industry-report/alopecia-market
brachytherapy market
https://www.google.com.ar/url?q=https://www.emergenresearch.com/industry-report/brachytherapy-market
depression treatment market
electrosurgical devices market
๐๐๐จ๐ฎ๐ญ ๐๐ฌ:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Thank you for reading our report. For further details or to inquire about customization, please let us know. We will offer you the report as per your needs.
Eric Lee
Emergen Research
+91 90210 91709
sales@emergenresearch.com
Visit us on social media:
Facebook
Twitter
LinkedIn
